Trilogy Capital’s Invesco S&P SmallCap 600 Pure Growth ETF RZG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$264K Sell
4,220
-52
-1% -$3.54K 0.01% 360
2026
Q2
$311K Buy
4,272
+10
+0.2% +$644 0.01% 322
2026
Q1
$243K Hold
4,262
– – 0.01% 355
2025
Q4
$232K Hold
4,262
– – 0.01% 359
2025
Q3
$232K Buy
+4,262
New +$225K 0.01% 353
2022
Q1
– Sell
-3,744
Closed -$208K – 198
2021
Q4
$208K Buy
+3,744
New +$207K 0.02% 163

Other funds holding RZG

Trilogy Capital's RZG Position: Q3 2026 in Review

Trilogy Capital reduced its Invesco S&P SmallCap 600 Pure Growth ETF (RZG) stake by 1.2% in Q3 2026, selling an estimated $3.54K and leaving 4,220 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #360.

Trilogy Capital first reported a position in RZG in Q4 2021 and has held it in 6 quarters since. The position peaked at $311K in Q2 2026. 8 funds tracked by Wall St. Rank hold RZG as of Q3 2026.

  • Trilogy Capital held 4,220 shares of Invesco S&P SmallCap 600 Pure Growth ETF worth $264K as of Q3 2026.
  • Trilogy Capital sold 52 Invesco S&P SmallCap 600 Pure Growth ETF shares in Q3 2026, an estimated $3.54K.
  • Invesco S&P SmallCap 600 Pure Growth ETF made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #360 holding.
  • Trilogy Capital first reported a position in Invesco S&P SmallCap 600 Pure Growth ETF in Q4 2021 and has held it in 6 quarters since.
  • Trilogy Capital's Invesco S&P SmallCap 600 Pure Growth ETF position peaked at $311K in Q2 2026.
  • 8 funds tracked by Wall St. Rank held Invesco S&P SmallCap 600 Pure Growth ETF as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.